If you are wondering whether GSK is still good value after its strong run, you are not alone. This article will walk through ...

GlaxoSmithKline ( ($GB:GSK) ) just unveiled an update. GSK has announced the purchase of 230,000 of its own ordinary shares as part of its ongoing ...

Secondary offerings from biotechs Immunovant, Kymera Therapeutics, and Wave Life Sciences prompted some huge insider buying ...

FDA approves GSK's Exdensur for severe eosinophilic asthma, backed by Phase 3 data showing up to 58% fewer asthma attacks ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

GlaxoSmithKline ( ($GB:GSK) ) has shared an update. GlaxoSmithKline (GSK) has announced a transaction involving the purchase of 217,000 of its own ...

We recently published 13 Best ADR Stocks to Invest In . GSK plc (NYSE:GSK) is one of the best ADR stocks.

Riad Mishlawi is stepping down from the top role by ‘mutual agreement’ with the firm’s board of directors, it told investors.

GSK secures FDA approval for its oral gonorrhoea drug as EMA backs expanded RSV vaccine and additional respiratory treatments ...

(Alliance News) - Outgoing GSK PLC Chief Executive Officer Emma Walmsley has said the US is the best place to invest, in the latest blow to Britain's pharmaceutical sector, after a raft of drugs firms ...

The London-based pharmaceuticals firm explained the approval for Exdensur is as an add-on maintenance treatment of severe asthma "characterised by an eosinophilic phenotype" in both adult and ...

(Alliance News) - GSK PLC on Monday said Exdensur has been approved in the UK, for the treatment of asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps.